About the Journal

Journal of Oncogenomics and Oncotarget is an international, peer-reviewed, open access journal committed to publishing high-quality research and scholarly contributions in the fields of oncogenomics, genetics, molecular biology, and therapeutic sciences. The journal provides a comprehensive platform for scientists, clinicians, researchers, and healthcare professionals to disseminate innovative discoveries, clinical developments, and theoretical insights that advance the understanding, diagnosis, prevention, and treatment of genetic and oncological disorders.

In an era characterized by rapid developments in genomic technologies, molecular medicine, and precision healthcare, the dissemination of reliable and impactful scientific knowledge is more important than ever. Journal of Oncogenomics and Oncotarget was established with the vision of promoting research excellence and facilitating the international exchange of scientific knowledge that connects fundamental laboratory discoveries with clinical practice and therapeutic applications.

The journal welcomes original, significant, and scientifically rigorous contributions that enhance the understanding of genetic and molecular mechanisms, disease pathogenesis, cancer biology, diagnostic approaches, genomic technologies, and therapeutic interventions. Through a strong commitment to scientific quality, research integrity, and ethical publishing practices, Journal of Oncogenomics and Oncotarget strives to ensure that all published work meets high academic and professional standards.

As an international publication, Journal of Oncogenomics and Oncotarget welcomes submissions from researchers, clinicians, academics, and institutions worldwide. The journal seeks to encourage interdisciplinary collaboration among experts from diverse scientific and medical backgrounds, promoting the exchange of knowledge, perspectives, and innovative ideas that can contribute to advances in oncogenomics, genetics, and therapeutic research.

The journal is committed to providing equal opportunities for researchers from all regions of the world to communicate their scientific findings. By encouraging global participation and diversity in scholarly publishing, Journal of Oncogenomics and Oncotarget supports the advancement of genomic and therapeutic sciences as globally relevant fields with significant implications for human health and disease management.

Peer Review Excellence

The journal follows a rigorous double-blind peer review process, ensuring that both authors and reviewers remain anonymous throughout the evaluation process. This approach eliminates bias and guarantees a fair, objective, and transparent review of all submitted manuscripts.

Each submission undergoes a thorough assessment by qualified experts in the relevant field, who evaluate the manuscript based on originality, scientific validity, methodological soundness, and relevance to the journal’s focus. The editorial board carefully considers reviewers’ feedback before making final decisions regarding acceptance, revision, or rejection.

To meet the needs of researchers requiring timely publication, the journal also offers a fast-track review process, enabling rapid evaluation and publication of high-priority manuscripts without compromising the quality of peer review. This feature is particularly beneficial for time-sensitive research findings and emerging scientific developments.

Open Access Policy and Creative Commons Licensing

Journal of Oncogenomics and Oncotarget operates under a full open access publishing model, ensuring that all articles are freely accessible to readers worldwide without subscription barriers. This approach enhances the dissemination and impact of research, allowing knowledge to reach a broader audience including researchers, clinicians, policymakers, and the general public.

All published articles are distributed under Creative Commons licensing, which permits users to read, download, copy, distribute, and reproduce the content in any medium, provided that appropriate credit is given to the original authors. This policy supports the principles of transparency, accessibility, and knowledge sharing in scientific research.

Open access publishing not only increases the visibility of authors’ work but also contributes to higher citation rates and broader academic recognition.

Digital Identification and Indexing Support

To ensure the long-term accessibility and traceability of published research, the journal assigns a Digital Object Identifier (DOI) to each article through Crossref. This enables accurate citation, easy retrieval, and integration with global research databases.

In addition, all published articles are submitted for indexing in Google Scholar after publication, enhancing discoverability and ensuring that research is accessible to the global academic community. The journal continuously works toward inclusion in additional indexing and abstracting databases to further expand its reach and credibility

Language and Accessibility

The journal publishes all manuscripts in English, the universally accepted language of scientific communication. This ensures clarity, consistency, and accessibility for an international audience.

Authors are encouraged to present their research in a clear and concise manner, enabling readers from diverse academic and professional backgrounds to understand and apply the findings effectively. The journal also supports the use of standardized scientific terminology and formatting to maintain consistency across publications.

Ethical Standards and Integrity

The journal is committed to maintaining the highest standards of publication ethics and academic integrity. All submissions are expected to be original and free from plagiarism, data fabrication, or any form of unethical practice.

Authors are required to disclose any potential conflicts of interest and ensure that their research complies with ethical guidelines, particularly in studies involving human participants or animals. The journal follows internationally recognized ethical standards to safeguard the credibility and reliability of published research.

By enforcing strict ethical policies, the journal ensures trust among authors, reviewers, and readers.

Contribution to Scientific Advancement

The primary goal of the Journal of Oncogenomics and Oncotarget is to contribute to the advancement of scientific knowledge and healthcare through the publication of high-quality research in oncogenomics, genetics, molecular sciences, and therapeutic research.

The journal encourages innovative and impactful studies that may contribute to the development of advanced diagnostic methods, improved understanding of disease mechanisms, targeted therapies, precision medicine approaches, and better clinical outcomes. It also supports research that facilitates the translation of fundamental scientific discoveries into meaningful clinical and practical applications.

Through its commitment to scientific excellence, open access, ethical publishing, and international collaboration, Journal of Oncogenomics and Oncotarget aims to serve as a valuable platform for researchers and healthcare professionals working to address complex challenges in genetic and oncological diseases.

By fostering innovation, encouraging interdisciplinary research, and promoting the broad dissemination of scientific knowledge, the journal supports global efforts to advance the understanding of disease mechanisms, improve diagnostic and therapeutic approaches, and promote personalized healthcare, ultimately contributing to better health outcomes and improved human well-being worldwide.